Page last updated: 2024-11-03

propranolol and Beckwith-Wiedemann Syndrome

propranolol has been researched along with Beckwith-Wiedemann Syndrome in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Beckwith-Wiedemann Syndrome: A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baranowski, S1
Winkler, A1
Kunzi-Rapp, K1
Schaal, M1
Hempel, S1
Debatin, KM1
Posovszky, C1

Other Studies

1 other study available for propranolol and Beckwith-Wiedemann Syndrome

ArticleYear
[Infantile hepatic hemangiomas: first-line propranolol monotherapy as new treatment strategy?].
    Klinische Padiatrie, 2012, Volume: 224, Issue:6

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Beckwith-Wiedemann Syndrome; Female; Follow-Up St

2012